Synergism between mutant HNF1A and the metabolic syndrome in Oji-Cree Type 2 diabetes

Diabetic Medicine

Volumn 22, Issue 11, 2005, Pages 1510-1515

  Pollex, R L ^a   Hanley, A J G ^b   Zinman, B ^b   Harris, S B ^c   Khan, H M R ^d   Hegele, R A ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Metabolic syndrome; North American Aboriginal population; Risk factors; Type 2 diabetes

Indexed keywords

HEPATIC NUCLEAR FACTOR 1ALPHA; NUCLEAR FACTOR I; UNCLASSIFIED DRUG;

ARTICLE; CANADA; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; RISK FACTOR;

ADULT; CANADA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; INDIANS, NORTH AMERICAN; MALE; METABOLIC SYNDROME X;

EID: 27844580651     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01697.x     Document Type: Article

References (30)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
2. Kylin E. Studien ueber das Hypertonie-Hyperglykamie-Hyperurikamiesyndrom. Zentralblatt Fuer Innere Med 1923; 44: 105-127.
3. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
4. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-422.
5. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 715-722.
6. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
7. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070-1077.
8. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-419.
9. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003; 26: 3153-3159.
10. Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the 'metabolic syndrome' and incidence of type 2 diabetes. Diabetes 2002; 51: 3120-3127.
11. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study. Diabetes Care 2003; 26: 861-867.
12. Young TK, Reading J, Elias B, O'Neil JD. Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress. CMAJ 2000;163:561-566.
13. Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao J et al. The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 1997; 20: 185-187.
14. Young TK. Obesity among aboriginal peoples in North America: epidemiological patterns, risk factors and metabolic consequences. In Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R eels. Progress in Obesity Research 7. London: John Libby 1996: 337-342.
15. Hegele RA. Genes, environment and diabetes in Canadian aboriginal communities. Adv Exp Med Biol 2001; 498: 11-20.
16. Hegele RA, Cao H, Harris SB, Hanley AJ, Zinman B. The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab 1999; 84: 1077-1082.
17. Triggs-Raine BL, Kirkpatrick RD, Kelly SL, Norquay LD, Cattini PA, Yamagata K et al. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proc Natl Acad Sci USA 2002; 99: 4614-4619.
18. Hegele RA, Cao H, Hanley AJ, Zinman B, Harris SB, Anderson CM. Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians. Diabetes Care 2000; 23: 775-778.
19. Hanley AJG, Harris SB, Barnie A, Gittelsohn J, Wolever TMS, Logan A et al. The Sandy Lake Health and Diabetes Project: design, methods and lessons learned. Chronic Dis Can 1995; 16: 149-156.
20. Hanley AJ, Harris SB, Gao XJ, Kwan J, Zinman B. Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM. Diabetes Care 1997; 20: 1408-1415.
21. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
22. Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003; 108: 420-425.
23. Kim MH, Kim MK, Choi BY, Shin YJ. Prevalence of the metabolic syndrome and its association with cardiovascular diseases in Korea. J Korean Med Sci 2004; 19: 195-201.
24. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC et al. Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord 2003; 27: 1283-1289.
25. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182-1186.
26. WHO consultation. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part I. Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999.
27. Wolever TM, Hamad S, Gittelsohn J, Gao J, Hanley AJ, Harris SB et al. Low dietary fiber and high protein intakes associated with newly diagnosed diabetes in a remote aboriginal community. Am J Clin Nutr 1997; 66: 1470-1474.
28. Gittelsohn J, Wolever TM, Harris SB, Harris-Giraldo R, Hanley AJ, Zinman B. Specific patterns of food consumption and preparation are associated with diabetes and obesity in a Native Canadian community. J Nutr 1998; 128: 541-547.
29. Kriska AM, Hanley AJ, Harris SB, Zinman B. Physical activity, physical fitness, and insulin and glucose concentrations in an isolated Native Canadian population experiencing rapid lifestyle change. Diabetes Care 2001; 24: 1787-1792.
30. Harris SB, Zinman B, Hanley A, Gittelsohn J, Hegele R, Connelly PW et al. The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population. Diabetes Res Clin Pract 2002; 55: 165-173.